Mérieux Equity Partners has acquired a majority stake in Nutragroup (holding company of Omnipharm and B-Pharma labs), via Mérieux Participations 3, its third generation fund dedicated to fast-growing companies in the health and nutrition sectors. Mehdi Boulahia, founder of the company, and Nutragroup management team will retain a significant equity interest in the business.
Founded in 2008 in Chambéry, Nutragroup has rapidly become a reference player in the food ingredient market, focusing on the supply, formulation and manufacturing of food supplements. Since its inception, the company has enjoyed a fast growth trajectory in France and abroad, with 40% of its revenues currently generated from international markets. Nutragroup opened a new 20,000 sq. feet facility last October, with the clear intention to become a European leader, based on its two main subsidiaries.
Omnipharm is a trusted business partner of food supplement and nutraceuticals companies for the selection and distribution of raw materials. B-Pharma is operating as a contract formulation and manufacturing company, which offers a complete turnkey service to industrial clients, from the supply of raw materials to the delivery of finished products.
